The Medicines Patent Pool Announces
First Licensing Agreement with a Pharmaceutical Company
London, 12 July 2011: Today the Medicines Patent Pool announces its first licenses with a pharmaceutical company, Gilead Sciences, to increase access to HIV and Hepatitis B treatment in developing countries.
Photo from Medicines Patent Pool web site
* * *
The Medicines Patent Pool and UNITAID joint press release is available here [pdf], and also posted below.
Questions and answers on the Patent Pool licenses are available here [pdf].
Per the Medicines Patent Pool transparency policy [pdf], the full texts of the licenses are posted below.
The main licensing agreement between the Medicines Patent Pool and Gilead is available here [pdf].
The amended and restated form is available here [pdf].
The form sublicensee agreement is available here [pdf].